Cann Global Ltd (CGB) Company Profile - CorporateInformation.com

Cann Global Ltd Company Snapshot

Cann Global Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cann Global Ltd with three other companies in this sector in AUSTRALIA : MGC Pharmaceuticals Ltd (2019 sales of 858,087.00 Australian Dollars [US$598,386.97 ] ), Anatara Lifesciences Ltd (663,405.00 Australian Dollars [US$462,625.48 ] ), and Recce Pharmaceuticals Ltd (686,622.00 Australian Dollars [US$478,815.85 ] ).

Sales Analysis. Sales fell dramatically in 2019: During the year ended June of 2019, sales at Cann Global Ltd were A$603,932.00 (US$421.15 thousand). This is a sharp decrease of 84.4% versus 2018, when the company's sales were A$3.87 million.

Cann Global Ltd

Stock Data:

Recent Stock Performance:

Current Price (7/3/2020): .01
(Figures in Australian Dollars)

1 Week	-16.7%	13 Weeks	n/a

4 Weeks	-28.6%	52 Weeks	n/a

Cann Global Ltd Key Data:

Ticker:	CGB	Country:	Australia

Exchanges:	FRA ASX	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Pharmaceutical Preparations

2019 Sales	603,932 (Year Ending Jan 2020).	Employees:	N/A

Currency:	Australian Dollars	Market Cap:	16,052,601

Fiscal Yr Ends:	June	Shares Outstanding:	3,210,520,210

Share Type:	Units	Closely Held Shares:	1,458,251,213

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.